ZA863703B - Methods and compositions for inhibiting lipoxygenase - Google Patents

Methods and compositions for inhibiting lipoxygenase

Info

Publication number
ZA863703B
ZA863703B ZA863703A ZA863703A ZA863703B ZA 863703 B ZA863703 B ZA 863703B ZA 863703 A ZA863703 A ZA 863703A ZA 863703 A ZA863703 A ZA 863703A ZA 863703 B ZA863703 B ZA 863703B
Authority
ZA
South Africa
Prior art keywords
compositions
methods
inhibiting lipoxygenase
lipoxygenase
inhibiting
Prior art date
Application number
ZA863703A
Other languages
English (en)
Inventor
Richard August Mueller
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ZA863703B publication Critical patent/ZA863703B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA863703A 1985-05-20 1986-05-19 Methods and compositions for inhibiting lipoxygenase ZA863703B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73688785A 1985-05-20 1985-05-20

Publications (1)

Publication Number Publication Date
ZA863703B true ZA863703B (en) 1987-07-29

Family

ID=24961736

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA863703A ZA863703B (en) 1985-05-20 1986-05-19 Methods and compositions for inhibiting lipoxygenase

Country Status (6)

Country Link
US (2) US4857558A (de)
EP (3) EP0338595B1 (de)
JP (1) JPS61268664A (de)
CA (2) CA1316932C (de)
DE (3) DE3686168T2 (de)
ZA (1) ZA863703B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162365A (en) * 1987-05-07 1992-11-10 G. D. Searle & Co. 5-lipoxygenase inhibitors
US5036105A (en) * 1987-05-07 1991-07-30 G. D. Searle & Co. 5-lipoxygenase inhibitors
US4847305A (en) * 1987-06-05 1989-07-11 G. D. Searle & Co. Phenolic thioethers as inhibitors of 5-lipoxygenase
CA1327050C (en) * 1987-06-05 1994-02-15 Richard August Mueller Phenolic thioethers, sulfoxides, and disulfides as inhibitors of 5-lipoxygenase
NZ226621A (en) * 1987-11-13 1991-12-23 Riker Laboratories Inc Di-tert butyl phenols substituted by alkoxy, benzyloxy, or benzylthio groups; pharmaceutical compositions containing them
US5066822A (en) * 1987-11-13 1991-11-19 Riker Laboratories, Inc Di-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
JP3065636B2 (ja) * 1989-06-29 2000-07-17 塩野義製薬株式会社 ［ジ―ｔｅｒｔ―ブチル（ヒドロキシ）フェニルチオ］置換ヒドロキサム酸誘導体
ATE119151T1 (de) * 1990-09-07 1995-03-15 Searle & Co Phenolische thioetheramide als 5-lipoxygenase- inhibitoren.
US5189038A (en) * 1990-09-07 1993-02-23 G. D. Searle And Co. Method of stimulating superoxide generation
US5082854A (en) * 1990-09-07 1992-01-21 G. D. Searle & Co. Method of stimulating superoxide generation
US5147893A (en) * 1991-05-09 1992-09-15 G. D. Searle & Co. Cyclic phenolic thioethers
US5250567A (en) * 1991-05-09 1993-10-05 G. D. Searle & Co. Cyclic phenolic thioethers
US5442111A (en) * 1991-05-24 1995-08-15 Warner-Lambert Company 3,5-di-tetriary-4-butyl-4-hydroxyphenyloxy- or tioalkylene N-hydroxyamides, N-hydroxythioamides, N-hydroxyureas, and N-hydroxythioureas as 5-lipoxygenase inhibitors
US5476944A (en) * 1991-11-18 1995-12-19 G. D. Searle & Co. Derivatives of cyclic phenolic thioethers
CA2291710A1 (en) * 1997-05-22 1998-11-26 Tatsuya Tamaoki Bisaryl compounds and cancer remedies containing the same
US7025985B2 (en) 2001-05-28 2006-04-11 Kanebo, Ltd. Dihydroxyphenyl compounds and glucoside compounds thereof
US20040014721A1 (en) * 2002-06-10 2004-01-22 Oklahoma Medical Research Foundation Method for using tethered bis(polyhydroxyphenyls) and O-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
US20130131140A1 (en) * 2010-01-14 2013-05-23 Jerry L. Nadler Treatment of diabetes and disorders associated with visceral obesity with inhibitors of human arachidonate 12 lipoxygenase and arachidonate 15-lipoxygenase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1175676A (en) * 1975-03-13 1977-09-15 Carter Wallace Suppressing histamine release
US4108831A (en) * 1975-06-02 1978-08-22 The Goodyear Tire & Rubber Company Hydroxyalkylthio phenolic antioxidants
US4029812A (en) * 1976-02-18 1977-06-14 The Dow Chemical Company Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
CA1165490A (en) * 1981-03-13 1984-04-10 Kirkwood S. Cottman Diester antioxidants
FR2509725A1 (fr) * 1981-07-15 1983-01-21 Choay Sa (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
AU594677B2 (en) 1990-03-15
EP0218782A1 (de) 1987-04-22
DE3687990T2 (de) 1993-07-15
DE3686168D1 (en) 1992-08-27
DE3686168T2 (de) 1993-01-14
US4857558A (en) 1989-08-15
EP0339688B1 (de) 1993-03-10
CA1320498C (en) 1993-07-20
CA1316932C (en) 1993-04-27
DE3687990D1 (en) 1993-04-15
EP0218782B1 (de) 1990-05-16
AU5752686A (en) 1986-11-27
EP0339688A1 (de) 1989-11-02
JPS61268664A (ja) 1986-11-28
EP0338595A1 (de) 1989-10-25
US5047593A (en) 1991-09-10
DE3671166D1 (de) 1990-06-21
EP0338595B1 (de) 1992-07-22

Similar Documents

Publication Publication Date Title
DE3666855D1 (en) Alcalisilicate compositions and their use
IL78934A0 (en) Alfuzosine compositions and use
GB8514052D0 (en) Compositions
GB8619046D0 (en) Compositions
DE3662194D1 (en) Lipoxygenase inhibitors
AR242340A1 (es) Material seleccionado entre extractos solubles en agua preparados a partir de tejidos de planta y fracciones separables de dichos extractos por cromatografia.
IL78592A0 (en) Antioxidant compositions and methods
NZ215216A (en) Pyridinylimidazolidinone compounds and herbicidal compositions
ZA863703B (en) Methods and compositions for inhibiting lipoxygenase
GB8509409D0 (en) Compositions
EP0230052A3 (en) Immunoamplifiers and related compositions
GB8514765D0 (en) Protective composition
EP0192630A3 (en) Aminomethylenephosphonate compositions
EP0228137A3 (en) Anaerobe-selective antibacterial compositions and methods
GB8513550D0 (en) Compositions
GB2237739B (en) Protective composition
GB8529409D0 (en) Aminomethylenephosphonate compositions
AU594677C (en) Methods and compositions for inhibiting lipoxygenase
GR860180B (en) Compositions and their use
GB8501400D0 (en) Compositions
GB8520289D0 (en) Compositions
GB8603048D0 (en) Lymphokine-containing compositions
GB2238475B (en) Protective composition
EG17458A (en) Fungicial compositions
ZA851092B (en) Compositions and methods